MedTrace Logo

Personalized, Predictive, Precise & Preventive Medicine for Major Depression

NCT06027177 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-09-07

No results posted yet for this study

Summary

Depressive disorders are among the most common psychiatric disorders. However, this disorder is multifaceted, as are its etiological factors, and is not yet fully understood. Within the framework of the P4D study, 1000 patients with depression will be comprehensively examined. In addition to the recording of psychological factors by means of questionnaires and third-party assessments, imaging and electrophysiological procedures (functional and structural MRI, EEG) are used to assess brain structure and function. In addition, blood is drawn from the subjects to analyze these samples for various biological markers (e.g., genetics). Drug level measurements are also performed.

The goal is to perform an in-depth characterization (phenotyping) of individuals with a depressive disorder. These findings could be used to individualize and improve therapy for depressive disorders.

Conditions

Sponsors & Collaborators

  • University Medicine Greifswald

    collaborator OTHER

  • Wuerzburg University Hospital

    collaborator OTHER

  • Goethe University

    collaborator OTHER

  • University Hospital Schleswig-Holstein

    collaborator OTHER

  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Helge Frieling, Prof. Dr.med · Hannover Medical School

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-30
Primary Completion
2025-08-31
Completion
2025-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06027177 on ClinicalTrials.gov